Bionano Genomics, Inc.
BNGONASDAQHealthcareMedical Instruments & Supplies
As of Oct 23, 2026 close
- Market cap
- $13.05M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.00$2.23
- Volume (live)
- -
- Avg. volume (3M)
- 1.81M
Bionano Genomics (BNGO) Stock Price & Financial Analysis
Bionano Genomics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.10 - $1.18 |
|---|---|
| 52-Week High | $2.23 |
| 52-Week Low | $1.00 |
| Open | $1.18 |
| Volume (last close) | 251.49K |
| Average Volume (3M) | 1.81M |
| Revenue (TTM) | 30.18M |
|---|---|
| Net Income (TTM) | -32.16M |
| Free Cash Flow (TTM) | -20.48M |
| EPS (TTM) | −$2.99 |
| Profit Margin | -106.58% |
| Operating Margin | -106.67% |
| Return on Equity (ROE) | -101.76% |
| Debt to Equity | 0.21 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 13.05M |
|---|---|
| Shares Outstanding | 11.55M |
| Price to Sales (P/S) | 0.43 |
| Price to Book (P/B) | 0.41 |
| EV/EBITDA | -0.76 |
| 50-Day MA | $1.38 |
|---|---|
| 200-Day MA | $1.26 |
| 1-Year Change | −38.22% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Bionano Genomics at a Glance
As of the Oct 23, 2026 close, Bionano Genomics (BNGO) has a market capitalization of $13.05M. The stock trades at 0.4× sales. Over the trailing twelve months it lost $32.16M on revenue of $30.18M and burned $20.48M of free cash flow. Revenue grew 2.2% year over year.
As of its latest reported balance sheet, it holds $3.73M in cash and securities against $6.70M of debt, a net debt position of $2.97M.
Bionano Genomics does not currently pay a dividend.
The share price is down 38.2% over the past year. At $1.13 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $1.00 to $2.23, below its 200-day moving average of $1.26.
Frequently Asked Questions About Bionano Genomics
What is the current stock price for BNGO?
As of the Oct 23, 2026 close, BNGO stock trades at $1.13. The 52-week range is $1.00–$2.23, with a day range of $1.10–$1.18.
What is the P/E ratio for BNGO?
The P/E ratio (Price-to-Earnings) for BNGO is shown in the Key Statistics section. This valuation metric helps compare Bionano Genomics, Inc. to industry peers.
Does BNGO pay dividends?
Bionano Genomics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for BNGO?
Analyst ratings and recommendations for BNGO are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of BNGO?
As of the Oct 23, 2026 close, Bionano Genomics's market capitalization is $13.0M, classifying it as a micro-cap company. Bionano Genomics operates in the Healthcare sector within the Medical Instruments & Supplies industry.